Premium
Murine CD8 lymphocyte expansion in vitro by artificial antigen‐presenting cells expressing CD137L (4‐1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour‐reactive effector cells in vivo
Author(s) -
Yan Xiaocai,
Johnson Bryon D.,
Orentas Rimas J.
Publication year - 2004
Publication title -
immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.297
H-Index - 133
eISSN - 1365-2567
pISSN - 0019-2805
DOI - 10.1111/j.1365-2567.2004.01853.x
Subject(s) - biology , cytotoxic t cell , antigen , cd8 , population , cd28 , ctl* , microbiology and biotechnology , immunology , in vitro , medicine , biochemistry , environmental health
Summary The ability to expand tumour‐infiltrating lymphocytes in vitro has been greatly enhanced by the use of antigen‐independent mechanisms of immune cell costimulation. We have produced human, using the K562 cell line, and murine, using YAC‐1 cells, artificial antigen presenting cells (aAPC) and demonstrate that these cell types stimulate murine lymphocyte populations in distinct ways. Using aAPC that have been transfected with CD137L (4‐1BBL) and CD32 (FcRγII), as a means to bind anti‐CD3 and anti‐CD28 antibody, we found that CD4 cells preferentially expanded in vitro with K562 aAPC, while CD8 cells expanded with both K562 and YAC‐1 aAPC. Co‐stimulation mediated by CD137L on aAPC was superior to that mediated by anti‐CD28 antibody. This was seen in both long and short‐term expansion assays, and by the rapid induction of a CD8 + DX5 + population. DX5 serves, under these in vitro conditions, as a general marker for lymphocyte activation. In vivo , the superiority of CD137L was demonstrated by the induction of T helper 1 effectors seen in freshly isolated splenocytes from mice immunized with CD137L‐expressing neuroblastoma tumour vaccines. The ability to stimulate a strong CD8 CTL response in vivo correlated with the induction of a DX5 + cell population in splenocytes with a memory‐effector phenotype. The presence of this unique DX5 + cell population, phenotypically distinct with regards to CD69 and CD62L expression from DX5 + cells induced by aAPC in vitro , may be associated with the ability of CD137L to induce strong anti‐tumour immunity.